CoppaGV, GabrielliO, BuzzegaDet al.Composition and structure elucidation of human milk glycosaminoglycans. Glycobiology, 2011; 21:295–303.
2.
CoppaGV, GabrielliO, ZampiniLet al.Glycosaminoglycan content in term and preterm milk during the first month of lactation. Neonatology, 2011; 101:74–76.
3.
BartheL, WoodleyJ, LavitMet al.In vitro intestinal degradation and absorption of chondroitin sulfate, a glycosaminoglycan drug. Arzneimittelforschung, 2004; 54:286–292.
4.
WadstromT, Ljunghl. Glycosaminoglycan-binding microbial proteins on tissue adhesion and invasion: Key events in microbial pathogenicity. J Med Microbiol, 1999; 48:223–233.
5.
Alberti-FidanzaA, BuriniG, PerrieloG. Total antioxidant capacity of colostrum, and transitional and mature human milk. J Matern Fetal Neonatal Med, 2002; 11:275–279.
6.
EgeaJ, GarciaAG, VergesJet al.Antioxidant antiinflammatory and neuroprotective actions of chondroitin sulfate and proteoglycans. Osteoarthritis Cartilage, 2010; 18,Suppl 1:S24–S27.
7.
VenturaM, CanchayaC, FitzgeraldGFet al.Genomics as a means to understand bacterial phylogeny and ecological adaptation: The case of bifidobacteria. Antonie Leeuwenhoek, 2007; 91:351–372.
